All Stories

  1. Matrix-Associated Gene Expression and Annotated Tumor–Stroma Composition of Transcriptomically Defined Cold Regions in Triple-Negative Breast Cancer
  2. Genomic and Functional Characterization of Lytic Tlsvirus Bacteriophages Targeting Salmonella Infantis Isolated from Poultry Farms in Ecuador
  3. Using Latent Dirichlet Allocation Topic Modeling to Uncover Latent Research Topics and Trends in Renal Cell Carcinoma: Bibliometric Review
  4. Neurotoxicity of mancozeb-based commercial fungicide in human neuroblastoma SH-SY5Y cells
  5. Hidden contaminants in e-liquids: Detection of microplastics and their potential human health risks
  6. Natural Fatty Acids as Dual ACE2-Inflammatory Modulators: Integrated Computational Framework for Pandemic Preparedness
  7. The impact of power outages on Ecuadorian science
  8. Role of brain cholecystokinin in neuronal homeostasis: rediscovering novel functions of an old neuropeptide
  9. In vitro Tolerance of Staphylococcus haemolyticus and Candida albicans Biofilms to Dalbavancin and Anidulafungin
  10. Preliminary Study on PCC-Chitosan’s Ability to Enhance Microplastic Excretion in Human Stools from Healthy Volunteers
  11. Benchmark doses (BMD) extrapolated from in vitro cytotoxicity experiments in SH-SY5Y cells using the EFSA Bayesian BMD web app: The study case of imidacloprid
  12. Enhanced Oil Binding Potential of Procambarus clarkii Chitosan (PCC): A Study with Extra Virgin Olive Oil and Sunflower Oil Under Simulated Gastric Conditions
  13. Plastic Smell: A Review of the Hidden Threat of Airborne Micro and Nanoplastics to Human Health and the Environment
  14. Red cell distribution width-to-platelet ratio (RPR) as a predictor of prolonged stay at hospital for COVID-19 inpatients
  15. Optimizing Predictive Models in Healthcare Using Artificial Intelligence: A Comprehensive Approach with a COVID-19 Case Study
  16. The new data access rules in ecuador present an opportunity for medical research in latin america
  17. Insights into the baseline blood pH homeostasis at admission and the risk of in-hospital mortality in COVID-19 patients
  18. Survival analysis of COVID-19 versus non-COVID-19 patients requiring intensive care for acute respiratory distress syndrome: An observational retrospective study
  19. Molecular docking analysis of chlorpyrifos at the human α7-nAChR and its potential relationship with neurocytoxicity in SH-SY5Y cells
  20. Genotoxic and neurotoxic potential of intracellular nanoplastics: A review
  21. Molecular Docking Analysis at the Human α7-nAChR and Proliferative and Evoked-Calcium Changes in SH-SY5Y Cells by Imidacloprid and Acetamiprid Insecticides
  22. Evaluation of the red blood cell distribution width-to-lymphocyte ratio (RLR) and red blood cell distribution width-to-platelet ratio (RPR) as predictors of COVID-19 in-hospital mortality
  23. Neurocytotoxicity of imidacloprid- and acetamiprid-based comercial insecticides over the differentiation of SH-SY5Y neuroblastoma cells
  24. Analysis of Socio-demographic, Economic and Individual Reasons for COVID-19 Vaccination Hesitancy in Ecuador: A Nationwide Longitudinal Study
  25. Anti-Inflammatory Therapy as a Promising Target in Neuropsychiatric Disorders
  26. Scientific pertinence of developing machine learning technologies for the triage of COVID-19 patients: A bibliometric analysis via Scopus
  27. Mean corpuscular haemoglobin concentration (MCHC): a new biomarker for high-altitude pulmonary edema in the Ecuadorian Andes
  28. Haematological indicators of mortality in people with community-acquired pneumonia living at high altitude
  29. Sex-Dependent Performance of the Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, Platelet-to-Lymphocyte and Mean Platelet Volume-to-Platelet Ratios in Discriminating COVID-19 Severity
  30. Biomarkers of severe COVID-19 pneumonia on admission using data-mining powered by common laboratory blood tests-datasets
  31. Does endogenous cholecystokinin modulate alcohol intake?
  32. Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A “Dimmer-Switch” Hypothesis
  33. Comparison between RT-qPCR for SARS-CoV-2 and expanded triage in sputum of symptomatic and asymptomatic COVID-19 subjects in Ecuador
  34. Common laboratory tests as indicators of COVID-19 severity on admission at high altitude: a single-center retrospective study in Quito (ECUADOR)
  35. Might a high hemoglobin mass be involved in non-cardiogenic pulmonary edema? The case of the chronic maladaptation to high-altitude in the Andes
  36. The Role of Brain Cyclooxygenase-2 (Cox-2) Beyond Neuroinflammation: Neuronal Homeostasis in Memory and Anxiety
  37. Overexpression of alpha-synuclein promotes both cell proliferation and cell toxicity in human SH-SY5Y neuroblastoma cells
  38. Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat
  39. Neurobiology of vitamin C: Expanding the focus from antioxidant to endogenous neuromodulator
  40. The unappreciated roles of the cholecystokinin receptor CCK(1) in brain functioning
  41. Interaction between cholecystokinin and the fibroblast growth factor system in the ventral tegmental area of selectively bred high- and low-responder rats
  42. Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons
  43. Striatal interaction among dopamine, glutamate and ascorbate
  44. Differential novelty detection in rats selectively bred for novelty-seeking behavior
  45. The CCK-system underpins novelty-seeking behavior in the rat: Gene expression and pharmacological analyses
  46. The CCK-system mediates adaptation to novelty-induced stress in the rat: A pharmacological evidence
  47. The 5-HT7 receptor: Role in novel object discrimination and relation to novelty-seeking behavior
  48. Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in novelty-seeking behavior
  49. Previous experience affects subsequent anxiety-like responses in rats bred for novelty seeking.
  50. The Potential Contributions of Chronic Inflammation to Lung Carcinogenesis
  51. Synthesis and Molecular Modeling of New 1-Aryl-3-[4-arylpiperazin-1-yl]-1-propane Derivatives with High Affinity at the Serotonin Transporter and at 5-HT1AReceptors
  52. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT1Areceptors
  53. 5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-Based Potent and Selective CCK1Receptor Antagonists:  Structural Modifications at the Tryptophan Domain
  54. MDMA (`Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion
  55. 2-Oxopyrrolidines and 6-Oxoperhydropyrrolo[1,2-a]pyrazines as Templates in the Search for Nonpeptide Cholecystokinin Ligands.
  56. Synthesis and Stereochemical Structure−Activity Relationships of 1,3-Dioxoperhydropyrido[1,2-c]pyrimidine Derivatives:  Potent and Selective Cholecystokinin-A Receptor Antagonists
  57. Pharmacological evaluation of IQM-95,333, a highly selective CCKAreceptor antagonist with anxiolytic-like activity in animal models
  58. Pseudopeptide CCK-4 analogues incorporating the Ψ[CH(CN)NH] peptide bond surrogate
  59. CCK-4 restricted analogues containing a 3-oxoindolizidine skeleton